Wang et al. [9] demonstrated the therapeutic potential of pyroptosis induction using a bioorthogonal system, where nanoparticle-mediated delivery of active gasdermin proteins to 4T1 breast tumor cells enhanced CD3-positive T cell infiltration and synergized with anti-PD-1 therapy to achieve significant tumor regression. Here, GSDMA is linked to neoplasm.